Diabetic peripheral neuropathy
Conditions
Interventions
control group:Methycobal
treatment group:Shenfu injection
blood-letting therapy group :Shenfu injection+blood-letting therapy of ten finger-tip points
Sponsors
the first Affiliated Hospital of Sun Yat - sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. clear history of diabetes; 2. after diagnosis of diabetes or neurological disease; 3. clinical symptoms and signs consistent with DPN: such as the extremities paresthesia and (or) sensory disorder, limb loss or muscle atrophy, Toronto clinical scoring system (TCSS) score more than 6 points; 4. nerve electrophysiological examination abnormal lower limb motor nerve conduction velocity (MNCV) of less than 45 m/s, the sensory nerve conduction velocity (SNCV) < 40m/s; 5. aged 18 ~ 80 years old; 6. sexes; 7. agreed to accept the Chinese and Western medicine treatment.
Exclusion criteria
Exclusion criteria: Other factors (such as cerebrovascular disease, cervical disease, alcoholism, uremia, hypothyroidism, drugs) - induced peripheral neuropathy; is involved in other clinical trials; pregnant and lactating women; with severe pneumonia, pulmonary tuberculosis, lung abscess, myocarditis and other malignant tumor patients; heart, liver and kidney function serious damage (heart function from 3 to 4, ALT and / or AST more than 2 times the upper limit of normal, Cr more than the upper limit of normal); a mental illness, not very good cooperation; cannot obtain informed consent; researchers think that do not fit into the patients in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurophysiological detection;Toronto clinical scoring system; | — |
Contacts
Public ContactJiuhui Liu
the first Affiliated Hospital of Sun Yat - sen University
Outcome results
None listed